Filing exhibits
- 8-K Current report
- 1.1 Underwriting Agreement, Dated As of February 6, 2024, by and Among Jasper Therapeutics, Inc., Cowen and Company, LLC and Evercore Group L.L.C
- 5.1 Opinion of Paul Hastings LLP
- 99.1 Jasper Therapeutics Announces Pricing of $50 Million Underwritten Offering of Common Stock
- Download Excel data file
- View Excel data file
Table of Contents